226 related articles for article (PubMed ID: 15249618)
1. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.
Kang JH; Weuve J; Grodstein F
Neurology; 2004 Jul; 63(1):101-7. PubMed ID: 15249618
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and cognitive function in healthy older women.
Grodstein F; Chen J; Pollen DA; Albert MS; Wilson RS; Folstein MF; Evans DA; Stampfer MJ
J Am Geriatr Soc; 2000 Jul; 48(7):746-52. PubMed ID: 10894312
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline.
Kang JH; Grodstein F
Neurobiol Aging; 2012 Jul; 33(7):1129-37. PubMed ID: 21122949
[TBL] [Abstract][Full Text] [Related]
4. Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women.
Kang JH; Grodstein F
Neurology; 2003 May; 60(10):1591-7. PubMed ID: 12771247
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
6. A gender difference in the association between APOE genotype and age-related cognitive decline.
Mortensen EL; Høgh P
Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
Carlson MC; Zandi PP; Plassman BL; Tschanz JT; Welsh-Bohmer KA; Steffens DC; Bastian LA; Mehta KM; Breitner JC;
Neurology; 2001 Dec; 57(12):2210-6. PubMed ID: 11756599
[TBL] [Abstract][Full Text] [Related]
8. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women.
Tworoger SS; Lee S; Schernhammer ES; Grodstein F
Alzheimer Dis Assoc Disord; 2006; 20(1):41-8. PubMed ID: 16493235
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.
Grodstein F; Manson JE; Stampfer MJ
Ann Intern Med; 2001 Jul; 135(1):1-8. PubMed ID: 11434726
[TBL] [Abstract][Full Text] [Related]
10. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
Yaffe K; Haan M; Byers A; Tangen C; Kuller L
Neurology; 2000 May; 54(10):1949-54. PubMed ID: 10822435
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use.
Maki PM
Ann N Y Acad Sci; 2005 Jun; 1052():182-97. PubMed ID: 16024761
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
Steffens DC; Norton MC; Plassman BL; Tschanz JT; Wyse BW; Welsh-Bohmer KA; Anthony JC; Breitner JC
J Am Geriatr Soc; 1999 Oct; 47(10):1171-5. PubMed ID: 10522948
[TBL] [Abstract][Full Text] [Related]
13. Natural history of cognitive decline in the old old.
Howieson DB; Camicioli R; Quinn J; Silbert LC; Care B; Moore MM; Dame A; Sexton G; Kaye JA
Neurology; 2003 May; 60(9):1489-94. PubMed ID: 12743237
[TBL] [Abstract][Full Text] [Related]
14. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.
MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW
Menopause; 2006; 13(1):28-36. PubMed ID: 16607096
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project.
Rice MM; Graves AB; McCurry SM; Gibbons LE; Bowen JD; McCormick WC; Larson EB
Arch Intern Med; 2000 Jun; 160(11):1641-9. PubMed ID: 10847257
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and risk of developing urinary incontinence.
Grodstein F; Lifford K; Resnick NM; Curhan GC
Obstet Gynecol; 2004 Feb; 103(2):254-60. PubMed ID: 14754692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
